BridgeMD
Compares treatment options for Club Foot
Official title Comparing Outcomes and Complications Following Mastisol Application for Clubfoot Casting
ClinicalTrials.gov ID: NCT07154550
What this study is testing
- What it's testing
- The purpose of this study is to assess if the application of Mastisol, a liquid adhesive, improves outcomes during bilateral clubfoot casting and reduces complications and development of complex clubfoot for the duration of their casting and up to 5 years follow-up.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 12
You may be able to join if
- Patients with bilateral clubfeet
- Starting standard of care treatment with the Ponseti method between 0-12 weeks of age
- For patients born pre-maturely their eligibility age will be based on a corrected gestational age
- Patients for whom at least one parent/guardian is able to converse, read, and write in English
You likely can't join if
- Patients who do not have bilateral clubfoot
- Patients who are starting treatment for clubfoot after 12 weeks of age
- Patients whose parents/guardians are unable to converse, read, and write in English
- Patients whose parents/guardian do not provide or are not able to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Madison, Wisconsin, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 weeks to 12 weeks. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Madison, Wisconsin, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.